What is LOPJLB’s current signal on ICU?

LOPJLB’s latest quantitative signal on SeaStar Medical Holding Corporation (ICU) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is ICU in?

SeaStar Medical Holding Corporation (ICU) is currently classified in the RECOVERY HMM market regime on LOPJLB.

SeaStar Medical Holding Corporation (ICU)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$3.85+6.65%Close

BUYRECOVERY · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $11M
Beta: -1.06
P/E (TTM): -0.82

Short % float: 5.10%
Days to cover: 3.2
SI change: +18.1%

1W: +8.45%
1M: +27.06%

vs SPY 1W: +8.03%
vs SPY 1M: +25.00%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing…

Employees: 18
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 2.8M
Float: 99.3%

seastarmedical.com ↗

Key executives

Eric Schlorff — Chief Executive Officer, Treasurer, President & Executive Director

Colonel Kevin Chung FACP — Chief Medical Officer

H. David Humes — Co-Founder & Scientific Advisor

SEC filings

EDGAR · CIK 18318680 · ICU

Analyst consensus

Buy

Bullish1100.0%

Neutral00.0%

Bearish00.0%

L $8.00Avg $8.00H $8.00

Target$8.00+107.79%

Last$3.85

FAQ

What is LOPJLB’s current signal on ICU?: LOPJLB’s latest quantitative signal on SeaStar Medical Holding Corporation (ICU) is BUY in a RECOVERY regime. Signals are updated daily.
What market regime is ICU in?: SeaStar Medical Holding Corporation (ICU) is currently classified in the RECOVERY HMM market regime on LOPJLB.
What does SeaStar Medical Holding Corporation (ICU) do?: SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a proc…

Key stats

Prediction markets

Company news

FAQ